A Long-term Safety Study of Infliximab (Remicade)
Completed
Conditions studied: Arthritis, Rheumatoid, Crohn Disease, Psoriasis
In brief
This is a study evaluating the long-term safety of infliximab (Remicade)
Key facts
- Study ID
- NCT00261976
- Run by
- Centocor, Inc.
- People needed
- 2971
- Starts
- 2002-02-01
- Expected to finish
- 2012-03-01
- Last updated by the study team
- 2014-03-18
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All patients enrolled in ongoing and future Centocor sponsored infliximab clinical studies that require long-term safety follow-up (ie, primary studies). Patients must have received at least 1 dose of study agent to be eligible for participation in the study
You may not qualify if…
- Did not previously participate in Centocor sponsored infliximab clinical studies.
Where it is running
- Study site — Huntsville, Alabama, United States
- Study site — Montgomery, Alabama, United States
- Study site — Paradise Valley, Arizona, United States
- Study site — Phoenix, Arizona, United States
- Study site — Tucson, Arizona, United States
- Study site — Little Rock, Arkansas, United States
- Study site — Anaheim, California, United States
- Study site — Fresno, California, United States
- Study site — Irvine, California, United States
- Study site — Los Angeles, California, United States
- Study site — Madera, California, United States
- Study site — Orange, California, United States
- Study site — Pasadena, California, United States
- Study site — Rancho Mirage, California, United States
- Study site — San Diego, California, United States
- Study site — Santa Monica, California, United States
- Study site — Stanford, California, United States
- Study site — Torrance, California, United States
- Study site — Denver, Colorado, United States
- Study site — Hamden, Connecticut, United States
- Study site — Hartford, Connecticut, United States
- Study site — New Haven, Connecticut, United States
- Study site — Waterbury, Connecticut, United States
- Study site — Aventura, Florida, United States
- Study site — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.